Jim Simons Impel Pharmaceuticals Inc Transaction History

Renaissance Technologies LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.96 - $4.1 $2,976 - $12,709	-3,100 Reduced 20.13%	12,300 $17,000
Q4 2022 Feb 13, 2023	SELL	$2.59 - $4.0 $5,180 - $8,000	-2,000 Reduced 11.49%	15,400 $58,000
Q3 2022 Nov 14, 2022	BUY	$5.78 - $9.32 $1,156 - $1,864	200 Added 1.16%	17,400 $85,000
Q2 2022 Aug 12, 2022	SELL	$5.83 - $10.12 $93,280 - $161,920	-16,000 Reduced 48.19%	17,200 $160,000
Q1 2022 May 13, 2022	BUY	$5.86 - $9.85 $194,552 - $327,020	33,200 New	33,200 $211,000

14.4K

Ticker IMPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,738,800
Market Cap $475K
Description
Impel Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for patients suffering from central nervous system disease in the United States. Its lead product candidate is Trudhesa, an upper nasal formulation of dihydroergotamine for the acute treatment of migraine. The c...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.